SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,188.00
-19.00 (-1.57%)
At close: Oct 2, 2025

SCM Lifescience Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
1,543824.8695.7395.98439.26320.01
Upgrade
Other Revenue
0----0-
Upgrade
1,543824.8695.7395.98439.26320.01
Upgrade
Revenue Growth (YoY)
53.75%18.56%75.69%-9.85%37.27%89.92%
Upgrade
Cost of Revenue
1,024511.75379.54245.84134.8294.2
Upgrade
Gross Profit
518.5313.05316.16150.14304.44225.8
Upgrade
Selling, General & Admin
2,9823,9063,8753,2091,4937,089
Upgrade
Research & Development
5,6817,5969,3159,31110,4738,846
Upgrade
Other Operating Expenses
32.0632.6732.1843.7392.6926.77
Upgrade
Operating Expenses
8,76611,62113,31412,72912,46016,315
Upgrade
Operating Income
-8,247-11,308-12,998-12,579-12,155-16,089
Upgrade
Interest Expense
-310.25-259.95-312.57-238.79-197.63-507.54
Upgrade
Interest & Investment Income
83.51238.7286.83246.86202.12178.69
Upgrade
Earnings From Equity Investments
---10,673-11,650-9,9999,186
Upgrade
Currency Exchange Gain (Loss)
-18.230.70.712.07-2.66-69.65
Upgrade
Other Non Operating Income (Expenses)
-214.17-291.47-6.54-11.44-3.99-2,113
Upgrade
EBT Excluding Unusual Items
-8,707-11,620-23,902-24,230-22,156-9,415
Upgrade
Gain (Loss) on Sale of Investments
-1,089-1,086-59.161,300-362.15-216.46
Upgrade
Gain (Loss) on Sale of Assets
1,214-267.05---0.48-1.38
Upgrade
Asset Writedown
-316.79-65.27----
Upgrade
Pretax Income
-8,899-13,038-23,961-22,930-22,519-9,633
Upgrade
Income Tax Expense
-661.37-661.37----
Upgrade
Net Income
-8,238-12,377-23,961-22,930-22,519-9,633
Upgrade
Net Income to Common
-8,238-12,377-23,961-22,930-22,519-9,633
Upgrade
Shares Outstanding (Basic)
232016151211
Upgrade
Shares Outstanding (Diluted)
232016151211
Upgrade
Shares Change (YoY)
10.66%25.01%12.85%21.21%12.79%101.51%
Upgrade
EPS (Basic)
-362.75-604.92-1464.00-1581.00-1882.00-908.00
Upgrade
EPS (Diluted)
-362.75-604.92-1464.00-1581.00-1882.00-908.00
Upgrade
Free Cash Flow
-16,552-14,127-12,372-11,689-14,080-12,370
Upgrade
Free Cash Flow Per Share
-728.88-690.44-755.88-805.93-1176.70-1165.98
Upgrade
Gross Margin
33.60%37.95%45.45%37.92%69.31%70.56%
Upgrade
Operating Margin
-534.51%-1370.97%-1868.29%-3176.64%-2767.18%-5027.71%
Upgrade
Profit Margin
-533.88%-1500.61%-3444.23%-5790.66%-5126.47%-3010.19%
Upgrade
Free Cash Flow Margin
-1072.73%-1712.75%-1778.30%-2951.85%-3205.28%-3865.43%
Upgrade
EBITDA
-7,350-10,449-12,158-11,538-11,020-14,858
Upgrade
D&A For EBITDA
896.89859.21839.441,0411,1361,231
Upgrade
EBIT
-8,247-11,308-12,998-12,579-12,155-16,089
Upgrade
Advertising Expenses
-208.18278.13146.98217.7148.49
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.